Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.73 EUR
−73.76 M EUR
0.00 EUR
28.57 M
About Leap Therapeutics, Inc.
Sector
Industry
CEO
Doug E. Onsi
Website
Headquarters
Cambridge
Founded
2011
FIGI
BBG00FYGGF48
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 5MC is 2.96 EUR — it hasn't changed in the past 24 hours. Watch LEAP THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LEAP THERAPEUTICS INC stocks are traded under the ticker 5MC.
5MC stock has fallen by −5.66% compared to the previous week, the month change is a 2.04% rise, over the last year LEAP THERAPEUTICS INC has showed a −6.33% decrease.
We've gathered analysts' opinions on LEAP THERAPEUTICS INC future price: according to them, 5MC price has a max estimate of 14.39 EUR and a min estimate of 5.28 EUR. Watch 5MC chart and read a more detailed LEAP THERAPEUTICS INC stock forecast: see what analysts think of LEAP THERAPEUTICS INC and suggest that you do with its stocks.
5MC stock is 0.68% volatile and has beta coefficient of 0.37. Track LEAP THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is LEAP THERAPEUTICS INC there?
Today LEAP THERAPEUTICS INC has the market capitalization of 114.90 M, it has decreased by −10.08% over the last week.
Yes, you can track LEAP THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
LEAP THERAPEUTICS INC is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
5MC earnings for the last quarter are −0.40 EUR per share, whereas the estimation was −0.44 EUR resulting in a 10.93% surprise. The estimated earnings for the next quarter are −0.39 EUR per share. See more details about LEAP THERAPEUTICS INC earnings.
LEAP THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
5MC net income for the last quarter is −16.32 M EUR, while the quarter before that showed −18.79 M EUR of net income which accounts for 13.13% change. Track more LEAP THERAPEUTICS INC financial stats to get the full picture.
No, 5MC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 15, 2025, the company has 54.00 employees. See our rating of the largest employees — is LEAP THERAPEUTICS INC on this list?
Like other stocks, 5MC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEAP THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEAP THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEAP THERAPEUTICS INC stock shows the strong buy signal. See more of LEAP THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.